Ask Warren

Komipharm International

041960 · KOSDAQ · ₩041960 · 코미팜

₩9,070▲ ₩320 (3.66%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩17B₩12B₩12B₩12B₩14B₩14B₩16B₩11B
Cost of sales₩10B₩7.4B₩8.4B₩8.7B₩8.6B₩9.7B₩11B₩7.1B
Gross profit₩6.7B₩4.6B₩3.5B₩3.7B₩5.1B₩4.7B₩4.3B₩3.9B
Operating income₩1.6B₩301M−₩241M₩66M₩1.6B₩509M₩376M₩897M
Net income−₩171M₩689M−₩7.7B₩3B−₩3.1B−₩126M₩5.8B₩4.1B
Net income to shareholders₩618M₩857M−₩3.9B−₩150M−₩3.2B₩47M₩761M₩6.5B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩139B₩134B₩134B₩134B₩122B₩123B₩123B₩133B
Current assets₩72B₩68B₩68B₩69B₩59B₩60B₩60B₩70B
Cash and equivalents₩21B₩19B₩28B₩25B₩19B₩16B₩12B₩27B
Total liabilities₩65B₩61B₩62B₩59B₩51B₩57B₩57B₩61B
Current liabilities₩55B₩52B₩53B₩34B₩39B₩46B₩46B₩53B
Borrowings₩41B₩40B₩40B₩41B₩39B₩44B₩43B₩44B
Total equity₩74B₩73B₩72B₩75B₩71B₩65B₩66B₩71B
Shareholders' equity₩72B₩71B₩70B₩72B₩68B₩62B₩62B₩65B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩1.7B−₩1.5B₩947M−₩178M−₩475M−₩916M₩3.1B₩1.9B
Capital spending₩550M₩413M₩1.7B₩777M₩534M₩112M₩460M₩156M
Free cash flow₩1.2B−₩1.9B−₩717M−₩955M−₩1B−₩1B₩2.6B₩1.8B

Consolidated where available. Amounts in won.

Also known as: Komipharm International / 코미팜 / 041960 / KRX:041960

Source: KRX statistical information